ISTITUTO EUROPEO DI ONCOLOGIA SRL - Italy 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:800-900
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:600-700
Total Number of Projects:500-600
Networking Rank (Reputation):500-600
Partner Constancy:300-400
Project Leadership Index:500-600
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:100-200
Total Number of Projects:300-400
Total Project Funding:100-200
Networking Rank (Reputation):400-500
Partner Constancy:400-500
Project Leadership Index:200-300
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:700-800
Total Number of Projects:> 1000
Total Project Funding:700-800
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:700-800
2009
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:500-600
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:100-200
Diversity Index:500-600
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:200-300
Total Number of Projects:300-400
Total Project Funding:300-400
Networking Rank (Reputation):500-600
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:100-200
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 42
As coordinator: 1
As participant: 40
Sole participant: 1
Coordinator / Participant Ratio: 0.03*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 10.607.311 703.900 1
2022 0 9.996.695 400.875 1
2021 0 28.292.673 2.039.038 4
2020 0 15.142.057 303.155 3
2019 0 13.930.695 488.125 2
2018 150.000 8.564.406 623.193 1 2
2017 0 25.445.853 2.057.166 4
2016 2.500.000 6.000.000 1.712.912 1 1
2015 0 25.593.416 1.475.955 6
2014 0 6.497.804 6.189.800 3
2013 0 4.263.618 453.174 2
2011 0 87.174.464 8.739.769 8
2010 0 18.392.711 433.097 3
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
EUROPEAN MOLECULAR BIOLOGY LABORATORY9
INSTITUT CURIE8
UNIVERSITY OF COPENHAGEN7
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM6
UNIVERSITA DEGLI STUDI DI MILANO6
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE5
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS5
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III5
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE5
UNIVERSITY COLLEGE LONDON5
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH4
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL4
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON4
HUMANITAS UNIVERSITY4
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE4
KAROLINSKA INSTITUTE4
KATHOLIEKE UNIVERSITEIT LEUVEN4
KING'S COLLEGE LONDON4
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD4
UPPSALA UNIVERSITET4
ACADEMISCH ZIEKENHUIS GRONINGEN3
CENTRE DE REGULACIO GENOMICA3
DEUTSCHES KREBSFORSCHUNGSZENTRUM3
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
FUNDACIO CENTRE DE REGULACIO GENOMICA3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
INSTITUT CATALA D'ONCOLOGIA3
INSTITUT GUSTAVE ROUSSY3
INSTITUT PASTEUR3
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN KNAW3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
LUNDS UNIVERSITET3
MASARYKOVA UNIVERZITA3
OSLO UNIVERSITETSSYKEHUS HF3
STICHTING KATHOLIEKE UNIVERSITEIT3
THE BABRAHAM INSTITUTE3
THE UNIVERSITY OF EDINBURGH3
UNIVERSITAET DES SAARLANDES3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITY OF CAMBRIDGE3
WEIZMANN INSTITUTE OF SCIENCE3
ACADEMISCH ZIEKENHUIS LEIDEN2
AGENCIA DE QUALITAT I AVALUACIO SANITARIES DE CATALUNYA2
ALLEANZA CONTRO IL CANCRO2
CELLZOME2
CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN2
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL2
CONSIGLIO NAZIONALE DELLE RICERCHE2
DIAGENODE2
ECANCERMEDICALSCIENCE2
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE2
EUROPEAN CANCER ORGANISATION2
EUROPEAN CANCER PATIENT COALITION2
F HOFFMANNLA ROCHE2
FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI2
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA2
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH2
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH FONDATION2
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE2
FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA2
GOETEBORGS UNIVERSITET2
GROUPEMENT EUROPEEN D INTERET ECONOMIQUE ORGANISATION OF EUROPEAN CANCER INSTITUTES OECI2
HEINRICHHEINEUNIVERSITAET DUESSELDORF2
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE2
INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS2
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER2
ISTITUTI FISIOTERAPICI OSPITALIERI2
KUNGLIGA TEKNISKA HOEGSKOLAN2
LUDWIGMAXIMILIANSUNIVERSITAET MUENCHEN2
MEDICAL RESEARCH COUNCIL2
MEDIZINISCHE UNIVERSITAT INNSBRUCK2
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS2
NOVARTIS FORSCHUNGSSTIFTUNG ZWEIGNIEDERLASSUNG FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH2
PFIZER LIMITED2
PHILIPS ELECTRONICS NEDERLAND B V2
POLYTECHNIC OF MILAN2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
REGION HOVEDSTADEN2
SYDDANSK UNIVERSITET2
TARTU ULIKOOL2
TECHNISCHE UNIVERSITEIT DELFT2
THE UNIVERSITY OF MANCHESTER2
THE UNIVERSITY OF TUEBINGEN2
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITAET LEIPZIG2
UNIVERSITAETSKLINIKUM FREIBURG2
UNIVERSITE DE GENEVE2
UNIVERSITEIT ANTWERPEN2
UNIVERSITY OF BIRMINGHAM2
UNIWERSYTET WARSZAWSKI2
USTAV MOLEKULARNI GENETIKY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYSKUMNA INSTITUCE2
VIB2
A PERSIDIS & SIA OE1
AALBORG UNIVERSITET1
AARHUS UNIVERSITETSHOSPITAL1
AARHUS UNIVERSITETSHOSPITAL SKEJBY1

Constancy:

Total number of partners: 566
Partner loyalty:
Frequent Partner: (> 2 projects): 176
Rare Partner: 390
Frequent / Rare Partner Ratio: 0.45

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe EUonQoLparticipant10.607.31127
2022-06-01Integrative science, Intelligent data platform for Individualized LUNG cancer care with Immunotherapy I3LUNGparticipant9.996.69516
2021-10-14European Cohorts of Patients and Schools to Advance Response to Epidemics EuCAREparticipant9.995.92018
2021-10-01Optimal treatment for patients with solid tumours in Europe through Artificial intelligence OPTIMAparticipant10.459.99739
2021-07-01EGFR signalling talks to mitochondria through contact sites EGFRtoMITOparticipant1.840.1252
2021-07-01AN INTERDISCIPLINARY APPROACH FOR THE MANAGEMENT OF THE ELDERLY MULTIMORBID PATIENT WITH BREAST CANCER THERAPY INDUCED CARDIAC TOXICITY CARDIOCAREparticipant5.996.63112
2020-07-01Deacetylase inhibitors for autism spectrum disorders: an integrated preclinical validation pipeline in brain organoids and in vivo models DUPDOWNparticipant150.0002
2020-03-01Molecular basis of human enhanceropathies ENHPATHYparticipant3.992.39717
2020-01-01NGS diagnostics in 21st century oncology: the best, for all, at all times oncNGSparticipant10.999.65918
2019-04-01AuTonomous intraLuminAl Surgery ATLASparticipant3.944.50921
2019-01-01European Proteomics Infrastructure Consortium providing Access EPIC-XSparticipant9.986.18618
2018-09-01Chromatin architecture and Design ChromDesignparticipant3.408.20717
2018-02-01EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts EDIReXparticipant5.156.19919
2018-01-01Immuno-targeting of human AML quiescent cells by a novel phage display approach. ITHACAcoordinator150.0001
2017-11-01Dissecting the Function of Multiple Polycomb Group Complexes in Establishing Transcriptional Identity DissectPcGparticipant2.000.0002
2017-11-01Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back BOUNCEparticipant4.999.4109
2017-01-01SMart weArable Robotic Teleoperated Surgery SMARTsurgparticipant3.990.20611
2017-01-01A Systems medicine approach to chronic inflammatory disease SYSCIDparticipant14.456.23616
2016-11-01The inflammatory gene expression program in macrophages: An integrative approach for the systematic characterization of transcriptional co-regulators MEDICIcoordinator2.500.0002
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2015-12-01Training Network for the Immunotherapy of Cancer IMMUTRAINparticipant3.627.52510
2015-10-01Leading Innovative measures to reach gender Balance in Research Activities LIBRAparticipant2.291.64111
2015-09-01Female cancer prediction using cervical omics to individualise screening and prevention FORECEEparticipant7.994.74614
2015-05-01Integrating Epidemiology and Experimental Biology to Improve Risk Assessment of Exposure to Mixtures of Endocrine Disruptive Compounds EDC-MixRiskparticipant6.223.33012
2015-02-01iManageCancer - Empowering patients and strengthening self-management in cancer diseases iManageCancerparticipant4.856.17410
2015-01-01European Consortium for Communicating Stem Cell Research EuroStemCellparticipant600.00031
2014-09-01Modeling Disease through Cell Reprogramming: a Translational Approach to the Pathogenesis of Syndromes Caused by Symmetrical Gene Dosage Imbalances DISEASEAVATARSparticipant1.997.8042
2014-07-01Inside mechanisms sustaining cancer stem cells INMECparticipant2.500.0001
2014-07-01Immune mechanisms that control the homeostasis of the gut and that are deregulated in intestinal pathologies cancer HOMEOGUTparticipant2.000.0002
2013-11-01Universal Flu Vaccine UNIVACFLUparticipant4.116.7018
2013-07-017kDa TSLP as a novel type of anti-inflammatory agent to re-establish immune homeostasis 7TREIMHOparticipant146.9172
2011-12-01Developing a global understanding of the PRC and NuRD complexes in stem cell differentiation, in health and disease 4DCELLFATEparticipant11.982.40313
2011-10-01A BLUEPRINT of Haematopoietic Epigenomes BLUEPRINTparticipant29.996.66445
2011-09-01Role of human papillomavirus infection and other co-factors in the aetiology of head and neck cancer in India and Europe HPV-AHEADparticipant2.999.94611
2011-07-01"Connecting the activities of c-Myc in genome regulation, cellular growth control and oncogenesis" MYCNEXTparticipant2.494.0001
2011-06-01The genomic blueprint of macrophages: dissecting players and mechanisms through an integrative approach NORMparticipant2.436.2001
2011-02-01From data sharing and integration via VPH models to personalised medicine p-medicineparticipant13.329.89819
2011-01-01A European Platform for Translational Cancer Research EUROCANPLATFORMparticipant11.998.45428
2011-01-01Systems biology of liver cancer: an integrative genomic-epigenomic approach MODHEPparticipant11.936.89918
2010-12-01Euro-BioImaging - Research infrastructure for imaging technologies in biological and biomedical sciences Euro-BioImagingparticipant5.198.24442
2010-07-01AnThocyanin and polyphenol bioactives for Health Enhancement through Nutritional Advancement ATHENAparticipant2.996.22613
2010-06-01Systems Biology of Mitosis MitoSysparticipant10.198.24114

Alias institution names:

  • ISTITUTO EUROPEO DI ONCOLOGIA